Our gain- and loss-of-function studies revealed that ABTB2 plays a pivotal tumor-suppressive role, significantly impairing PDAC cell oncogenicity in vitro and tumorigenesis in vivo. This evidence concerns the gene ABTB2 and neoplasm.